Health
Inside the mind of criminals: How to brazenly steal $100 billion from Medicare and Medicaid
A nondescript suite of offices in a bland building tucked in a quiet Miami suburb seemed as good a place as any for a medical supply company to rent some office space. But this company rented space two floors above a regional office of the U.S. Department of Health and Human Services’ criminal investigative unit. […]
Read More
California will not renew $54 million contract with Walgreens over abortion pill policy
A Walgreens store in San Francisco, California, US, on Tuesday, March 7, 2023. David Paul Morris | Bloomberg | Getty Images California will not renew a $54 million contract with Walgreens over the drug store chain’s decision not to sell the abortion pill in some states due to legal restrictions. “California will not stand by […]
Read More
Eli Lilly Alzheimer’s treatment solanezumab failed to slow disease progression
Eli Lilly on Wednesday said it will halt development of its Alzheimer’s treatment candidate solanezumab after the antibody failed to slow disease progression. Solanezumab’s failure is a blow to efforts to treat Alzheimer’s in people who are in the very early stage of the disease and have not yet shown clinical symptoms. The study enrolled […]
Read More
Under threat, Weight Watchers enters obesity drug space. Here’s what it means for the stock
WW International is steering hard in a new direction, hoping to turn the growing interest in obesity medications to its advantage. On paper, the new strategy could be the answer to its problems, but significant execution risks remain. Shares of the Weight Watchers parent are up nearly 50% on Tuesday after the company announced plans […]
Read More
Republican states say the FDA doesn’t have the authority to override state abortion pill bans
Boxes of the medication Mifepristone used to induce a medical abortion are prepared for patients at Planned Parenthood health center in Birmingham, Alabama, March 14, 2022. Evelyn Hockstein | Reuters The Food and Drug Administration’s power to approve drugs does not override state bans on the abortion pill, a coalition of Republican attorneys general told […]
Read More
When quality stocks go on sale in a rough market, we like to go shopping. Here’s our latest buy
After keeping our powder dry since the end of February, we’re making one small buy into weakness Tuesday. Source
Read More
Best Buy will set up in-home hospital care through a new deal with Atrium Health
Best Buy is best known for installing TVs and home theater systems. Now, its Geek Squad is helping to set up virtual hospital rooms. The consumer electronics retailer said Tuesday it has struck a three-year deal with Atrium Health, a North Carolina-based health-care system, to help enable a hospital-at-home program. Atrium Health is part of […]
Read More
Jim Cramer’s Investing Club meeting Monday: Fed and jobs, China reopening, Eli Lilly
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Fed and jobs report Stick with China reopening stocks Watch Eli Lilly 1. Fed and jobs report Stocks were trading higher Monday as investors look ahead to Federal Reserve commentary […]
Read More
Marlboro maker Altria agrees to buy e-cigarette startup NJOY for nearly $2.8 billion
In a bid to strengthen its portfolio of smoke-free products, Altria Group said Monday it would buy e-cigarette startup NJOY for $2.75 billion. Altria, which makes Marlboro cigarettes, will have full global ownership of NJOY’s e-vapor product portfolio, including NJOY ACE, the only pod-based e-vapor product with market authorizations from the FDA. “We believe we […]
Read More
FDA will review Eisai’s and Biogen’s Alzheimer’s treatment Leqembi with decision on full approval expected in early July
Andrew Brookes | Image Source | Getty Images The Food and Drug Administration will make a decision on whether to fully approve Eisai‘s and Biogen‘s Alzheimer’s treatment Leqembi by July 6, the companies announced on Monday. Leqembi is an antibody treatment that targets brain plaque associated with the mind-robbing disease. It is administered intravenously twice […]
Read More